Compile Data Set for Download or QSAR
maximum 50k data
Found 33 of ec50 for UniProtKB: Q9GZT9
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences

Curated by ChEMBL
LigandPNGBDBM50607013(CHEMBL5219134)
Affinity DataEC50:  10nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO production measured after 24 hrs by ELISAMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences

Curated by ChEMBL
LigandPNGBDBM50607011(CHEMBL5219277)
Affinity DataEC50:  100nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO production measured after 24 hrs by ELISAMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences

Curated by ChEMBL
LigandPNGBDBM50607009(CHEMBL5218673)
Affinity DataEC50:  190nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO production measured after 24 hrs by ELISAMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences

Curated by ChEMBL
LigandPNGBDBM50607010(CHEMBL5218720)
Affinity DataEC50:  1.25E+3nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO production measured after 24 hrs by ELISAMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences

Curated by ChEMBL
LigandPNGBDBM50286248(CHEMBL4168030)
Affinity DataEC50:  4.20E+3nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences

Curated by ChEMBL
LigandPNGBDBM50607012(CHEMBL5220549)
Affinity DataEC50:  4.46E+3nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO production measured after 24 hrs by ELISAMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences

Curated by ChEMBL
LigandPNGBDBM50286228(CHEMBL4174643)
Affinity DataEC50:  4.50E+3nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISAMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences

Curated by ChEMBL
LigandPNGBDBM50286072(CHEMBL4164403)
Affinity DataEC50:  4.70E+3nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences

Curated by ChEMBL
LigandPNGBDBM50607007(CHEMBL5219872)
Affinity DataEC50:  4.91E+3nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO production measured after 24 hrs by ELISAMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences

Curated by ChEMBL
LigandPNGBDBM50607006(CHEMBL5218506)
Affinity DataEC50:  5.54E+3nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO production measured after 24 hrs by ELISAMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences

Curated by ChEMBL
LigandPNGBDBM50286071(CHEMBL4166742)
Affinity DataEC50:  5.70E+3nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences

Curated by ChEMBL
LigandPNGBDBM50286233(CHEMBL4175892)
Affinity DataEC50:  5.80E+3nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences

Curated by ChEMBL
LigandPNGBDBM50286068(CHEMBL4171201)
Affinity DataEC50:  5.80E+3nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences

Curated by ChEMBL
LigandPNGBDBM50286250(CHEMBL4159751)
Affinity DataEC50:  5.80E+3nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences

Curated by ChEMBL
LigandPNGBDBM50431015(CHEMBL2338329 | US10889546, FG-4592 | US9115085, C...)
Affinity DataEC50:  6.11E+3nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO production measured after 24 hrs by ELISAMore data for this Ligand-Target Pair
In DepthDetails PubMed
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences

Curated by ChEMBL
LigandPNGBDBM50607008(CHEMBL5218607)
Affinity DataEC50:  7.97E+3nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO production measured after 24 hrs by ELISAMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences

Curated by ChEMBL
LigandPNGBDBM50607005(CHEMBL5219927)
Affinity DataEC50:  9.27E+3nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO production measured after 24 hrs by ELISAMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences

Curated by ChEMBL
LigandPNGBDBM50286251(CHEMBL4167844)
Affinity DataEC50:  9.30E+3nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences

Curated by ChEMBL
LigandPNGBDBM50286231(CHEMBL4175056)
Affinity DataEC50:  1.20E+4nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences

Curated by ChEMBL
LigandPNGBDBM50286263(CHEMBL4167657)
Affinity DataEC50:  1.30E+4nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences

Curated by ChEMBL
LigandPNGBDBM50286230(CHEMBL4171371)
Affinity DataEC50:  1.40E+4nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISAMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences

Curated by ChEMBL
LigandPNGBDBM50286232(CHEMBL4173606)
Affinity DataEC50:  1.40E+4nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences

Curated by ChEMBL
LigandPNGBDBM50286070(CHEMBL4166512)
Affinity DataEC50:  1.50E+4nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences

Curated by ChEMBL
LigandPNGBDBM50286224(CHEMBL4162891)
Affinity DataEC50:  1.70E+4nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences

Curated by ChEMBL
LigandPNGBDBM102348(US10562854, No. A41 | US8536181, A41 | US9278930, ...)
Affinity DataEC50:  1.70E+4nMAssay Description:Inhibition of PHD2 in HEK293 cells assessed as VEGF release by immunoassayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences

Curated by ChEMBL
LigandPNGBDBM50286245(CHEMBL4163070)
Affinity DataEC50:  1.90E+4nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences

Curated by ChEMBL
LigandPNGBDBM50286249(CHEMBL4159929)
Affinity DataEC50:  2.10E+4nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences

Curated by ChEMBL
LigandPNGBDBM50286246(CHEMBL4159695)
Affinity DataEC50: >3.00E+4nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences

Curated by ChEMBL
LigandPNGBDBM50286229(CHEMBL4167612)
Affinity DataEC50: >3.00E+4nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences

Curated by ChEMBL
LigandPNGBDBM50286227(CHEMBL4160770)
Affinity DataEC50: >3.00E+4nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences

Curated by ChEMBL
LigandPNGBDBM50286069(CHEMBL4174815)
Affinity DataEC50: >3.00E+4nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences

Curated by ChEMBL
LigandPNGBDBM50286247(CHEMBL4164159)
Affinity DataEC50: >3.00E+4nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences

Curated by ChEMBL
LigandPNGBDBM50193145(2-(1-chloro-4-hydroxyisoquinoline-3-carboxamido)ac...)
Affinity DataEC50:  7.90E+4nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISAMore data for this Ligand-Target Pair